Ingrid Nordgren, Swedish pharmaceutical executive. Achievements include research on basic pharmacology of metrifonate; analysis of succinylcholine in biological material; analysis of cholinergic agonists, pharmacology of cholinesterase inhibitors; research on drugs for treatment of Alzheimer's disease. Member Swedish Academy Pharmaceutical Sciences, European Federation for Pharmaceutical Sciences, Drug Information Association.
Research chemist Karolinska Institute, Stockholm, 1971-1993. Clinical research scientist Astra Arcus AB, Sweden, 1994-1996, preclinical coordinator Sweden, 1997-1998. Regulatory affairs director Astra Zeneca Research and Development, Sweden, since 1999.
World Health Organization temporary advisor International Program on Chemical Safety, Geneva, 1991. Consultant Astra Arcus AB, Sweden, 1993.